Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
Authors
Keywords
-
Journal
Molecular Diagnosis & Therapy
Volume 26, Issue 1, Pages 7-18
Publisher
Springer Science and Business Media LLC
Online
2021-11-23
DOI
10.1007/s40291-021-00563-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effect of Advances in Lung-Cancer Treatment on Population Mortality
- (2020) Nadia Howlader et al. NEW ENGLAND JOURNAL OF MEDICINE
- Value of Precision Medicine in Advanced Non‐Small Cell Lung Cancer: Real‐World Outcomes Associated With the Use of Companion Diagnostics
- (2020) Ani John et al. ONCOLOGIST
- Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice
- (2020) Charu Aggarwal et al. Nature Reviews Clinical Oncology
- Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
- (2019) Carlo Buonerba et al. Cancers
- Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain
- (2018) Edurne Arriola et al. BMC CANCER
- Complex epidermal growth factor receptor mutations and their responses to tyrosine kinase inhibitors in previously untreated advanced lung adenocarcinomas
- (2018) Bo Zhang et al. CANCER
- Tivantinib in Combination with Erlotinib versus Erlotinib Alone for EGFR- Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study
- (2018) Giorgio V. Scagliotti et al. Journal of Thoracic Oncology
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- (2018) Neal I. Lindeman et al. Journal of Thoracic Oncology
- Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer
- (2018) C.C.H.J. Kuijpers et al. LUNG CANCER
- Tumor biomarker testing in non-small-cell lung cancer: A decade of change
- (2018) Paul A. VanderLaan et al. LUNG CANCER
- EGFR mutations in early-stage and advanced-stage lung adenocarcinoma: Analysis based on large-scale data from China
- (2018) Can Pi et al. Thoracic Cancer
- Early radiological response as predictor of overall survival in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor mutations
- (2018) Carmen Salvador-Coloma et al. Journal of Thoracic Disease
- Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
- (2018) Min Young Baek et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas
- (2018) Ying Jin et al. LUNG CANCER
- The Clinicopathological and Molecular Associations of PD-L1 Expression in Non-small Cell Lung Cancer: Analysis of a Series of 10,005 Cases Tested with the 22C3 Assay
- (2018) Matthew Evans et al. PATHOLOGY & ONCOLOGY RESEARCH
- Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
- (2018) Ying Cheng et al. Thoracic Cancer
- Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations
- (2018) Hongwei Li et al. GENES AND IMMUNITY
- EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)
- (2018) Alejandro Ruiz-Patiño et al. Targeted Oncology
- Lung Cancer Biomarkers
- (2017) Pamela Villalobos et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Clinical profile and outcomes of patients with Stage IV adenocarcinoma of lung: A tertiary cancer center experience
- (2017) S Rajappa et al. INDIAN JOURNAL OF CANCER
- Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations
- (2017) Yi-Cheng Shen et al. LUNG CANCER
- EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand
- (2017) Mark McKeage et al. Targeted Oncology
- Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
- (2017) Emmet J. Jordan et al. Cancer Discovery
- Prognostic and predictive value of serum carcinoembryonic antigen levels in advanced non-small cell lung cancer patients with epidermal growth factor receptor sensitive mutations and receiving tyrosine kinase inhibitors
- (2017) Xin Min Zhao et al. Oncotarget
- Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma
- (2017) Yuki Matsumura et al. Interactive Cardiovascular and Thoracic Surgery
- Clinical profile and outcomes of patients with Stage IV adenocarcinoma of lung: A tertiary cancer center experience
- (2017) S Rajappa et al. INDIAN JOURNAL OF CANCER
- Comparison of clinical and radiological characteristics between anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in treatment naïve advanced lung adenocarcinoma
- (2017) Yingying Miao et al. Journal of Thoracic Disease
- Zoledronic acid as potential efficacy application combined with icotinib for non-small cell lung cancer with bone metastases
- (2017) Wenxian Wang et al. Translational Cancer Research
- Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases
- (2017) Guowei Zhang et al. Scientific Reports
- Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials
- (2016) S. S. Ramalingam et al. ANNALS OF ONCOLOGY
- The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
- (2016) Yuki Sato et al. BMC CANCER
- New and emerging targeted treatments in advanced non-small-cell lung cancer
- (2016) Fred R Hirsch et al. LANCET
- Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation
- (2016) Janani Vigneswaran et al. Oncotarget
- The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis
- (2016) Yue-Lun Zhang et al. Oncotarget
- First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer
- (2016) Keunchil Park et al. JAMA Oncology
- Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium
- (2015) Conor E. Steuer et al. CANCER
- EGFR Mutation Status and First-Line Treatment in Patients with Stage III/IV Non-Small Cell Lung Cancer in Germany: An Observational Study
- (2015) W. Schuette et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The correlation between EGFR mutation status and the risk of brain metastasis in patients with lung adenocarcinoma
- (2015) Bo Li et al. JOURNAL OF NEURO-ONCOLOGY
- Fitting Linear Mixed-Effects Models Usinglme4
- (2015) Douglas Bates et al. Journal of Statistical Software
- Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe
- (2015) Rodryg Ramlau et al. Journal of Thoracic Oncology
- Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients
- (2015) Y.-H. Tseng et al. ONCOLOGIST
- The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
- (2015) Yanna Tang et al. Oncotarget
- Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973–2010
- (2015) Rafael Meza et al. PLoS One
- SNPs in the transforming growth factor-β pathway as predictors of outcome in advanced lung adenocarcinoma with EGFR mutations treated with gefitinib
- (2014) L. Zhang et al. ANNALS OF ONCOLOGY
- Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
- (2014) K. M. Kerr et al. ANNALS OF ONCOLOGY
- TheBimdeletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non-small cell lung cancer
- (2014) Mingchuan Zhao et al. CANCER
- Effects of Icotinib on Advanced Non-Small Cell Lung Cancer with Different EGFR Phenotypes
- (2014) Huiyun Pan et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients
- (2014) Shuai Wang et al. CLINICA CHIMICA ACTA
- Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis
- (2014) Daichi Fujimoto et al. CLINICAL & EXPERIMENTAL METASTASIS
- Prognostic Significance of Genotype and Number of Metastatic Sites in Advanced Non–Small-Cell Lung Cancer
- (2014) Yan-yan He et al. Clinical Lung Cancer
- First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial
- (2014) James Chih-Hsin Yang et al. EUROPEAN JOURNAL OF CANCER
- Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease
- (2014) A. D. Campos-Parra et al. EUROPEAN RESPIRATORY JOURNAL
- A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
- (2014) Yuankai Shi et al. Journal of Thoracic Oncology
- A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)
- (2014) Xingsheng Hu et al. LUNG CANCER
- Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: Integrating with lung specific GPA score
- (2014) Dae-Won Lee et al. LUNG CANCER
- Suitability of Surgical Tumor Tissues, Biopsy, or Cytology Samples for Epidermal Growth Factor Receptor Mutation Testing in Non–Small Cell Lung Carcinoma Based on Chinese Population
- (2014) Xiaohong Han et al. Translational Oncology
- Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients
- (2014) Stoyan Naidenov Bichev et al. CELLULAR ONCOLOGY
- Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)
- (2013) S. Dearden et al. ANNALS OF ONCOLOGY
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
- (2013) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice
- (2013) S Gahr et al. BRITISH JOURNAL OF CANCER
- Response to First-Line Chemotherapy in Patients With Non–Small-Cell Lung Cancer According to Epidermal Growth Factor Receptor and K-RAS Mutation Status
- (2013) Xiaopeng Dong et al. Clinical Lung Cancer
- Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma in Malaysian Patients
- (2013) Chong-Kin Liam et al. Journal of Thoracic Oncology
- Challenges to Implementation of an Epidermal Growth Factor Receptor Testing Strategy for Non–Small-Cell Lung Cancer in a Publicly Funded Health Care System
- (2013) Peter M. Ellis et al. Journal of Thoracic Oncology
- Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
- (2013) Yuankai Shi et al. LANCET ONCOLOGY
- Economic burden of cancer across the European Union: a population-based cost analysis
- (2013) Ramon Luengo-Fernandez et al. LANCET ONCOLOGY
- Routine EGFR Molecular Analysis in Non-Small-Cell Lung Cancer Patients is Feasible: Exons 18–21 Sequencing Results of 753 Patients and Subsequent Clinical Outcomes
- (2013) Myriam Locatelli-Sanchez et al. LUNG
- Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancer
- (2013) Jong-Mu Sun et al. LUNG CANCER
- EGFR mutation frequency and effectiveness of erlotinib: A prospective observational study in Danish patients with non-small cell lung cancer
- (2013) Britta Weber et al. LUNG CANCER
- Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma
- (2013) Rong-li Lu et al. PATHOLOGY & ONCOLOGY RESEARCH
- The Introduction of Systematic Genomic Testing for Patients with Non–Small-Cell Lung Cancer
- (2012) Stephanie Cardarella et al. Journal of Thoracic Oncology
- Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
- (2012) James Chih-Hsin Yang et al. LANCET ONCOLOGY
- EGFR mutations as a predictive marker of cytotoxic chemotherapy
- (2012) Jin Hyun Park et al. LUNG CANCER
- Association between vascular-poor area of primary tumors and epidermal growth factor receptor gene status in advanced lung adenocarcinoma
- (2012) Yosuke Togashi et al. MEDICAL ONCOLOGY
- Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
- (2012) Eric Faulkner et al. VALUE IN HEALTH
- EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
- (2012) Alexander J. J. Smits et al. CELLULAR ONCOLOGY
- Clinical Significance of Thyroid Transcription Factor-1 in Advanced Lung Adenocarcinoma Under Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment
- (2011) Kuei-Pin Chung et al. CHEST
- EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: A meta-analysis
- (2011) Jing-Hua Ren et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer: A Combined Clinical-Molecular Pathological Approach
- (2011) Manuel Salto-Tellez et al. Journal of Thoracic Oncology
- Screening for EGFR mutations in lung cancer, a report from India
- (2011) Rashmita Sahoo et al. LUNG CANCER
- When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology
- (2010) Dan Greenberg et al. JNCI-Journal of the National Cancer Institute
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy
- (2008) Chih-Hsin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now